Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 17, Issue 3, Pages 155-163
http://dx.doi.org/10.1155/2006/402409
Special Article

Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients

Anita Rachlis,1 Jonathan Angel,2 Marianne Harris,3 Richard Lalonde,4 Fiona Smaill,5 Cecile Tremblay,6 Chris Tsoukas,7 and Sharon Walmsley8

1Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada
2Division of Infectious Diseases, Department of Medicine, Ottawa Hospital and University of Ottawa, Ottawa, Ontario, Canada
3AIDS Research Program, St Paul’s Hospital, Vancouver, British Columbia, Canada
4Immunodeficiency Service and Division of Infectious Diseases, McGill University Health Centre, Montreal, Quebec, Canada
5Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
6UHRESS, Centre Hospitalier de l’Université de Montréal, Canada
7Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
8Division of Infectious Diseases, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada

Received 28 November 2005; Accepted 28 April 2006

Copyright © 2006 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Anita Rachlis, Jonathan Angel, Marianne Harris, et al., “Canadian Consensus Recommendations for the Optimal Use of Enfuvirtide in HIV/AIDS Patients,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 17, no. 3, pp. 155-163, 2006. https://doi.org/10.1155/2006/402409.